Finance ❯ Investments ❯ Stock Market ❯ Public Companies

Securities Fraud

Soleno Therapeutics Investors Face May 5 Deadline to Seek Lead Role in Securities Class Action

The push highlights a fight over what Soleno told investors about its Prader‑Willi drug VYKAT XR.

Lufax Investors Urged to Seek Lead Role in Securities Suit as May 20 Deadline Nears

Law Firms Urge PayPal Investors to Seek Lead Role in Securities Case Before April 20

Securities Class Action Filed Against ImmunityBio After FDA Flags Anktiva Marketing

Investor Lawsuits Target Gossamer Bio Over Failed PROSERA Trial

Law Firms Set April 7 Deadline for Investors to Lead Inovio Securities Class Action

Driven Brands Faces Securities Class Action in SDNY as Law Firms Rally Investors

Law Firms Step Up Enphase Investor Solicitation Before April 20 Lead-Plaintiff Deadline

Beyond Meat Faces Wave of Securities Class Actions Over Asset Impairment Disclosures

Bath & Body Works Faces Investor Class Action Over 'Adjacencies' Claims With Lead‑Plaintiff Motions Due in March

Investor Firms Step Up DeFi Technologies Class Action as Lead‑Plaintiff Deadline Nears

Skye Bioscience Faces Investor Class Actions as Firms Court Shareholders Before Jan. 16 Deadline

Stride Investors Sought for Lead Roles in Securities Suits Over Alleged Enrollment Inflation and Tech Failures

Fiserv Faces Securities Class Action After Q3 Earnings Shock and Outlook Cut